Immunopharmacology Comments

Muromonab-CD3 binds to CD3 on T cells and induces Fc mediated apoptosis, antibody mediated cytotoxicity and complement-dependent cytotoxicity.

Immunopharmacology Disease
Disease	X-Refs	Comment	References
Allograft rejection		Approved to prevent renal, cardiac and hepatic allograft rejection. Withdrawn from the US market.